BioVaxys Technology Corp. (CSE: BIOV)

BioVaxys Technology Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Cash & Equivalents	0.49	0	0.14	0.59	2.42	0.23
Cash & Short-Term Investments	0.49	0	0.14	0.59	2.42	0.23
Cash Growth	115939.01%	-99.31%	-76.08%	-75.52%	958.21%	-
Other Receivables	0.38	0.09	0.05	0.05	0.05	0
Receivables	0.38	0.09	0.21	0.13	0.05	0
Prepaid Expenses	0.16	0.02	0.36	0.15	0.59	-
Other Current Assets	-	-	-	-	-	0.08
Total Current Assets	1.02	0.11	0.71	0.87	3.06	0.31
Other Intangible Assets	1.38	-	-	7.4	7.4	-
Total Assets	2.41	0.11	0.87	8.5	10.46	0.31
Accounts Payable	1.51	2.66	1.31	0.22	0.75	0.04
Accrued Expenses	1.06	0.83	0.33	0.11	0.15	0.08
Total Current Liabilities	2.66	3.49	1.64	0.33	0.9	0.12
Total Liabilities	2.66	3.49	1.64	0.33	0.9	0.12
Common Stock	26.12	21.99	17.05	14.76	10.75	0.57
Retained Earnings	-28.51	-27.3	-19.61	-8.02	-1.56	-0.39
Comprehensive Income & Other	2.14	1.93	1.78	1.44	0.37	0.01
Shareholders' Equity	-0.25	-3.37	-0.77	8.18	9.56	0.19
Total Liabilities & Equity	2.41	0.11	0.87	8.5	10.46	0.31
Net Cash (Debt)	0.41	0	0.14	0.59	2.42	0.23
Net Cash Growth	96741.37%	-99.31%	-76.08%	-75.52%	958.21%	-
Net Cash Per Share	0.00	0.00	0.00	0.01	0.09	0.02
Filing Date Shares Outstanding	256.03	220.24	115.25	99.66	81.53	10.39
Total Common Shares Outstanding	241.91	145.11	108.81	92.19	74.07	10.39
Working Capital	-1.63	-3.37	-0.92	0.55	2.16	0.19
Book Value Per Share	-0.00	-0.02	-0.01	0.09	0.13	0.02
Tangible Book Value	-1.63	-3.37	-0.77	0.78	2.16	0.19
Tangible Book Value Per Share	-0.01	-0.02	-0.01	0.01	0.03	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.